Lincoln Pharmaceuticals Limited is engaged in manufacturing and trading of pharmaceutical products, with a focus on areas such as anti-infective, gynecology, and anti-diabetic segments.

The company's roots date back to 1979 and it was founded by members of the Patel family. It became a public limited company in 1995.

Lincoln Pharmaceuticals has developed an extensive manufacturing setup, including a modern formulation plant in Khatraj, Gujarat, to support production of diverse pharmaceutical forms.

The company underwent significant expansion after acquiring a plant for Cephalosporin products and merging with Lincoln Parenteral Limited, strengthening its production capabilities.

In recent years, Lincoln Pharmaceuticals launched innovative products like the Next Generation Progesterone Therapy 'ProlinSpray', marking its commitment to R&D and innovation.